Our research provides new genetic evidence for the protective effect of SLC22A5 in rosacea; the MR results of blood showed that the expression of SLC22A5 was negatively correlated with the risk of rosacea (OR = 0.79, p = 5.08E‐29). Here, SLC22A5 is linked to rosacea.